Skip to main content
SpringerLink
Log in

Human Leukocyte Antigen-G (HLA-G) Expression in Cervical Lesions: Association With Cancer Progression, HPV 16/18 Infection, and Host Immune Response

  • Original Article
  • Published:
Reproductive Sciences Aims and scope Submit manuscript

Abstract

Human leukocyte antigen-G (HLA-G) expression in 55 cervical intraepithelial neoplasia (CIN) patients with or without human papillomavirus (HPV) infection and 116 patients with squamous cell cervical cancer were examined using immunohistochemistry. Host immune response was assessed by estimating the number of intratumoral lymphocyte infiltration (TIL) in all lesions and counting CD57-expressing cells in the neoplasm lesions. The means of HLA-G immunoreactive scores were compared by the Mann-Whitney test and 1-way analysis of variance (ANOVA). The association of HLA-G expression with disease progression, HPV infection and host immune response was calculated using the Pearson Chi-square test. It was found that HLA-G expression increasingly progressed from patients with CIN 1 to CIN 2/3 and was highest in patients with cervical cancer. Human leukocyte antigen-G expression was also significantly higher in CIN and cancer patients with HPV 16/18 than in CIN patients without HPV. A significant correlation between HLA-G expression and TIL score or the counting of CD57-expressing cells was also evident in CIN patients with HPV infection and cervical cancer cases. These results suggest that HLA-G expression in cervical lesions is associated with carcinogenesis, HPV infection, and host immune response.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Pisani P, Bray F, Parkin DM. Estimates of the worldwide prevalence of cancer for 25 sites in the adult population. Int J Cancer. 2002;97(1):72–81.

    Article  CAS  Google Scholar 

  2. Burd, EM. Human Papillomavirus and Cervical Cancer. Clin Microbiol Rev. 2003;16(1):1–17.

    Article  CAS  Google Scholar 

  3. Vermeulen CFW, Ekaterina S, Jordanova ES, et al. Frequent HLA Class I loss is an early event in cervical carcinogenesis. Hum Immunol. 2005;66(11):1167–1173.

    Article  CAS  Google Scholar 

  4. Hicklin DJ, Marincola FM, Ferrone S. HLA class I antigen down-regulation in human cancers: T-cell immunotherapy revives an old story. Mol Med Today. 1999;5(4):178–186.

    Article  CAS  Google Scholar 

  5. Goncalves MA, Le Discorde M, Simoes RT, et al. Classical and non-classical HLA molecules and p16(INK4a) expression in precursors lesions and invasive cervical cancer. Eur J Obstet Gynecol Reprod Biol. 2008;141(1):70–74.

    Article  CAS  Google Scholar 

  6. Zhou JH, Ye F, Chen HZ, Zhou CY, Lu WG, Xie X. Altered expression of cellular membrane molecules of HLA-DR, HLA-G and CD99 in cervical intraepithelial neoplasias and invasive squamous cell carcinoma. Life Sci. 2006;78(22):2643–2649.

    Article  CAS  Google Scholar 

  7. Yoon BS, Kim YT, Kim JW, Kim SH, Kim JH, Kim SW. Expression of human leukocyte antigen-G and its correlation with interleukin-10 expression in cervicalcarcinoma. Int J Gyn Obs. 2007;98(1):48–53.

    Article  CAS  Google Scholar 

  8. Guimarães MCM, Soares CP, Donadi EA, et al. Low expression of human histocompatibility soluble leukocyte antigen G (HLA-5) in invasive cervical cancer with and without metastasis, associated with papilloma virus (HPV) [Epub ahead of print.]. J Hist Cytochem. 2009; DOI: 10.1369/jhc.2009.954131.

    Article  Google Scholar 

  9. Carosella ED, Moreau P, Lemaoult J, Rouas-Freiss N. HLA-G: from biology to clinical benefits. Trends Immunol. 2008;29(3):125–132.

    Article  CAS  Google Scholar 

  10. Urosevic MJ, Dummer R. Human Leukocyte Antigen–G and Cancer Immunoediting. Cancer Res. 2008;68(3):627–630.

    Article  CAS  Google Scholar 

  11. Onno M, Pangault C, Le Friec G, Guilloux V, Andre P, Fauchet R. Modulation of HLA-G antigens expression by human cytomegalovirus: specific induction in activated macrophages harboring human cytomegalovirus infection. J Immunol. 2000;164(12):6426–6434.

    Article  CAS  Google Scholar 

  12. Lozazo JM, Gonzalez R, Kindelan JM, et al. Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule. AIDS. 2002;16(3):347–351.

    Article  Google Scholar 

  13. Lafon M, Prehaud C, Megret F, et al. Modulation of HLA-G expression in human neural cells after neurotropic viral infections. J Virol. 2005;79(24):15226–15237.

    Article  CAS  Google Scholar 

  14. de Oliveira CF, Mota F. Cervical cancer—pre-therapeutic investigations and clinical staging versus surgical staging. CME J Gynecol Oncol. 2001;6:246–256.

    Google Scholar 

  15. Ye SR, Yang H, Li K, Dong DD, Lin XM, Yie SM. Human leukocyte antigen G expression: as a significant prognostic indicator for patients with colorectal cancer. Mod Pathol. 2007;20(3):375–383.

    Article  CAS  Google Scholar 

  16. Yie SM, Yang H, Ye SR, Li K, Dong DD, Lin XM. Expression of HLA-G is associated with prognosis in esophageal squamous cell carcinoma. Am J Clin Pathol. 2007;128(6):1002–1009.

    Article  Google Scholar 

  17. Yie SM, Yang H, Ye SR, Li K, Dong DD, Lin XM. Expression of human leucocyte antigen G (HLA-G) is associated with prognosis in non-small cell lung cancer. Lung Cancer. 2007;58(2):267–274.

    Article  Google Scholar 

  18. Yie SM, Yang H, Ye SR, Li K, Dong DD, Lin XM. Expression of human leukocyte antigen G (HLA-G) correlates with poor prognosis in gastric carcinoma. Ann Surg Oncol. 2007;14(10):2721–2729.

    Article  Google Scholar 

  19. He X, Dong DD, Yie SM, et al. HLA-G expression in human breast cancer: implications for diagnosis and prognosis, and effect on allo-cytotoxic lymphocyte response after hormone treatment in vitro [Epub ahead of print.]. Ann Surg Oncol. 2009; DOI: 10.1245/s10434-009-0891-9.

    Article  Google Scholar 

  20. Walboomers JMM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12–19.

    Article  CAS  Google Scholar 

  21. Jung YW, Kim YT, Kim SW, et al. Correlation of human leukocyte antigen-G (HLA-G) expression and disease progression in epithelial ovarian cancer. Reproductive Sciences. 2009;16(11):1103–1111.

    Article  CAS  Google Scholar 

  22. Barrier BF, Kendall BS, Sharpe-Timms KL, Kost WR. Characterization of human leukocyte antigen-G (HLA-G) expression in endometrial adenocarcinoma. Gynecol Oncol. 2006;103(1):25–30.

    Article  CAS  Google Scholar 

  23. Lin A, Chen HX, Zhu CC, et al. Aberrant human leukocyte antigen-G expression and its clinical relevance in hepatocellular carcinoma. J Cell Mol Med. 2009 Oct 3. [Epub ahead of print].

  24. Kanodia S, Fahey LM, Kast WM. Mechanisms used by human papillomaviruses to escape the host immune response. Current cancer targets. 2007;7(1):79–89.

    Article  CAS  Google Scholar 

  25. Hildesheim A, Wang SS. Host and viral genetics and risk of cervical cancer: a review. Virus Res. 2002;89(2):229–240.

    Article  CAS  Google Scholar 

  26. Simoes RT, Goncalves MA, castelli EC, et al. HLA-G polymorphisms in women with squamous intraepithelial lesions harboring human papillomavirus. Mod Pathol. 2009;22(8):1075–1082.

    Article  CAS  Google Scholar 

  27. Galon J, Costes A, Sanchez-Cabo F, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science. 2006;313(5795):1960–1964.

    Article  CAS  Google Scholar 

  28. Cai MY, Xu YF, Qiu SJ, et al. Human leukocyte antigen-G protein expression is an unfavorable prognostic predictor of hepatocellular carcinoma following curative resection. Clin Cancer Res. 2009;15(14):4686–4693.

    Article  CAS  Google Scholar 

  29. Cutts FT, Franceschi S, Goldie S, et al. Human papillomavirus and HPV vaccines: a review. Bull World Health Organ. 2007;85(9):719–726.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Sichuan Academy of Medical Sciences, Sichuan Provincial People’s Hospital, Chengdu, Sichuan, PR China

    Dan-dan Dong MD, Hong Yang MD, Ke Li BM, Gang Xu MD, Lin-hong Song MD, Xiao-li Fan BM & Xin-lian Jiang MD

  2. Core Laboratory, Sichuan Academy of Medical Sciences, Sichuan Provincial People’s Hospital, 32 Yi Huan Lu Xi Er Duan, 610072, Chengdu, Sichuan, PR China

    Shang-mian Yie PhD

Authors
  1. Dan-dan Dong MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hong Yang MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ke Li BM
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gang Xu MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Lin-hong Song MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Xiao-li Fan BM
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Xin-lian Jiang MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Shang-mian Yie PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shang-mian Yie PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dong, Dd., Yang, H., Li, K. et al. Human Leukocyte Antigen-G (HLA-G) Expression in Cervical Lesions: Association With Cancer Progression, HPV 16/18 Infection, and Host Immune Response. Reprod. Sci. 17, 718–723 (2010). https://doi.org/10.1177/1933719110369183

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/1933719110369183

Keywords

Search

Navigation